GRI Bio Statistics

Total Valuation

GRI Bio has a market cap or net worth of $3.22 million. The enterprise value is -$7.77 million.

Market Cap	3.22M
Enterprise Value	-7.77M

Important Dates

The next estimated earnings date is Thursday, August 13, 2026, before market open.

Earnings Date	Aug 13, 2026
Ex-Dividend Date	n/a

Share Statistics

GRI Bio has 1.77 million shares outstanding. The number of shares has increased by 3,546.32% in one year.

Current Share Class	1.77M
Shares Outstanding	1.77M
Shares Change (YoY)	+3,546.32%
Shares Change (QoQ)	+518.40%
Owned by Insiders (%)	0.00%
Owned by Institutions (%)	2.80%
Float	1.77M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.27
P/TBV Ratio	0.31
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.21, with a Debt / Equity ratio of 0.01.

Current Ratio	14.21
Quick Ratio	13.91
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -185.67% and return on invested capital (ROIC) is -114.65%.

Return on Equity (ROE)	-185.67%
Return on Assets (ROA)	-88.82%
Return on Invested Capital (ROIC)	-114.65%
Return on Capital Employed (ROCE)	-103.64%
Weighted Average Cost of Capital (WACC)	0.63%
Revenue Per Employee	n/a
Profits Per Employee	-$2.73M
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -95.19% in the last 52 weeks. The beta is -0.66, so GRI Bio's price volatility has been lower than the market average.

Beta (5Y)	-0.66
52-Week Price Change	-95.19%
50-Day Moving Average	2.20
200-Day Moving Average	19.65
Relative Strength Index (RSI)	38.38
Average Volume (20 Days)	122,231

Short Selling Information

The latest short interest is 134,230, so 7.58% of the outstanding shares have been sold short.

Short Interest	134,230
Short Previous Month	123,491
Short % of Shares Out	7.58%
Short % of Float	7.58%
Short Ratio (days to cover)	2.67

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-10.93M
Pretax Income	-10.91M
Net Income	-10.91M
EBITDA	-10.93M
EBIT	-10.93M
Earnings Per Share (EPS)	-$27.02

Full Income Statement

Balance Sheet

The company has $11.05 million in cash and $58,000 in debt, giving a net cash position of $10.99 million or $6.21 per share.

Cash & Cash Equivalents	11.05M
Total Debt	58,000
Net Cash	10.99M
Net Cash Per Share	$6.21
Equity (Book Value)	10.55M
Book Value Per Share	6.65
Working Capital	10.49M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$12.14 million and capital expenditures -$3,000, giving a free cash flow of -$12.14 million.

Operating Cash Flow	-12.14M
Capital Expenditures	-3,000
Depreciation & Amortization	4,000
Net Borrowing	n/a
Free Cash Flow	-12.14M
FCF Per Share	-$6.85

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GRI Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3,546.32%
Shareholder Yield	-3,546.32%
Earnings Yield	-338.45%
FCF Yield	-376.61%

Analyst Forecast

The average price target for GRI Bio is $21.00, which is 1,053.85% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$21.00
Price Target Difference	1,053.85%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 26, 2026. It was a reverse split with a ratio of 1:28.

Last Split Date	Jan 26, 2026
Split Type	Reverse
Split Ratio	1:28

Scores

Altman Z-Score	n/a
Piotroski F-Score	1